Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.5K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.5K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

393
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
393

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activating KIR Haplotype Influences Clinical Outcome Following HLA-Matched Sibling Hematopoietic Stem Cell Transplantation.

HLA·2018
Same author

The Rationale of Malaria Treatment in Syphilis of the Central Nervous System.

The Indian medical gazette·2017
Same author

Transmission of Kala-Azar in India: The Case against the Sandfly.

The Indian medical gazette·2017
Same author

Correspondence.

The Indian medical gazette·2017
Same author

Use of Anticoagulants in the Treatment of Experimental Yellow Fever.

The Indian medical gazette·2017
Same author

The Rationale of Malaria Therapy in Late Localized Syphilis with Particular Reference to General Paralysis of the Insane.

The Indian medical gazette·2017
Same journal

Notes on Some Remedies. XIX. Drugs in Anæmias. Part III.

The Indian medical gazette·2017
Same journal

Current Topics.

The Indian medical gazette·2017
Same journal

Medical News.

The Indian medical gazette·2017
Same journal

Work for Welfare of the Blind.

The Indian medical gazette·2017
Same journal

Some Aspects of Family Planning Rajkumari Amrit Kaur's Broadcast.

The Indian medical gazette·2017
Same journal

Role of Non-Political Agencies in Easing World Tensions Stressed by Prime Minister Nehru before WHO Regional Committee.

The Indian medical gazette·2017
See all related articles

Related Experiment Video

Updated: Feb 21, 2026

A Protocol for Collecting and Staining Hemocytes from the Yellow Fever Mosquito Aedes aegypti
08:33

A Protocol for Collecting and Staining Hemocytes from the Yellow Fever Mosquito Aedes aegypti

Published on: May 16, 2011

15.9K

Heparin in Yellow Fever

M L Ahuja1, A G Brooks1

  • 1Central Research Institute, Kasauli.

The Indian Medical Gazette
|October 11, 2017
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity
10:41

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity

Published on: February 17, 2017

8.5K
A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
07:06

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum

Published on: April 10, 2018

9.2K

Related Experiment Videos

Last Updated: Feb 21, 2026

A Protocol for Collecting and Staining Hemocytes from the Yellow Fever Mosquito Aedes aegypti
08:33

A Protocol for Collecting and Staining Hemocytes from the Yellow Fever Mosquito Aedes aegypti

Published on: May 16, 2011

15.9K
Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity
10:41

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity

Published on: February 17, 2017

8.5K
A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
07:06

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum

Published on: April 10, 2018

9.2K